CI Investments Inc
IRWD icon

CI Investments Inc’s Ironwood Pharmaceuticals IRWD Stock Holding History

CI Investments Inc’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-56,357
Closed -$736K – 1355
2021
Q3 		$736K Buy
+56,357
New +$728K ﹤0.01% 501
2020
Q1 		– Sell
-43,288
Closed -$576K – 595
2019
Q4 		$576K Buy
+43,288
New +$477K ﹤0.01% 413

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

CI Investments Inc's IRWD Position: Q4 2021 in Review

CI Investments Inc sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2021, closing a stake of 56,357 shares — an estimated $736K sold.

CI Investments Inc first reported a position in IRWD in Q4 2019 and held it in 2 quarters. The position peaked at $736K in Q3 2021. 212 funds tracked by Wall St. Rank hold IRWD as of Q4 2021.

  • CI Investments Inc reported no remaining Ironwood Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • CI Investments Inc sold 56,357 Ironwood Pharmaceuticals shares in Q4 2021, an estimated $736K.
  • CI Investments Inc first reported a position in Ironwood Pharmaceuticals in Q4 2019 and held it in 2 quarters.
  • CI Investments Inc's Ironwood Pharmaceuticals position peaked at $736K in Q3 2021.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2021.

Based on CI Investments Inc's 13F filing for Q4 2021, filed 11 Feb 2022.